← Back to Search

Avatar Therapy vs Supportive Care for Cannabis Use in Psychotic Disorders (AC2 Trial)

N/A

Recruiting

Led By Stephane Potvin, PhD

Research Sponsored by Ciusss de L'Est de l'Île de Montréal

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 1 week before treatment, within 1 week after treatment, follow-ups at 3 months, 6 months and 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will compare two interventions to reduce cannabis use in people with psychotic disorders to see which works better. Results will show if it reduces cannabis use, cannabis use disorder severity, and improves quality of life.

Who is the study for?

This trial is for adults over 18 with schizophrenia, schizoaffective disorder, or bipolar disorder with psychotic symptoms who also have a cannabis use problem. They must not be currently treated for other substance use disorders, detoxing from cannabis, have neurological issues or severe physical illnesses.

What is being tested?

The study is testing if an 'Avatar Intervention' is more effective than standard supportive care in helping people with psychotic disorders reduce their cannabis use. Participants are randomly assigned to one of the two interventions without knowing which one they're getting.

What are the potential side effects?

Since this trial involves psychological interventions rather than medications, side effects may include emotional discomfort or distress related to discussing personal issues and confronting cannabis use habits.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 1 week before treatment, within 1 week after treatment, follow-ups at 3 months, 6 months and 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 1 week before treatment, within 1 week after treatment, follow-ups at 3 months, 6 months and 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 1 week before treatment, within 1 week after treatment, follow-ups at 3 months, 6 months and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in cannabis use (Timeline Follow-Back)

Secondary study objectives

Change in quality of life(Quality of Life Enjoyment and Satisfaction Questionnaire - QLESQ-SF & Quality of Life Scale - QLS)

Change in the severity of the cannabis use disorder (Cannabis Use Problems Identification Test - CUPIT)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Avatar InterventionExperimental Treatment1 Intervention

The Avatar Intervention will take place over 8 consecutive weeks, with one session per week. Additional sessions (up to a maximum of 4 sessions) will be offered if needed. Each session will last approximately 60 minutes. The goal of the intervention will be to help you reduce cravings related to your cannabis use with the use of virtual reality and avatars.

Group II: Addiction supportive interventionActive Control1 Intervention

The Addiction supportive intervention will take place over 8 consecutive weeks, with one session per week. Additional sessions (up to a maximum of 4 sessions) will be offered if needed. Each session will last approximately 60 minutes. The goal of the intervention will be to help you reduce cravings related to your cannabis use.

Do I qualify?Apply below to find out